Loading...
1332 logo

Touyun Biotech Group LimitedSEHK:1332 Stock Report

Market Cap HK$373.2m
Share Price
n/a
1Y33.7%
7D-2.9%
1D1.5%
Portfolio Value
View

Touyun Biotech Group Limited

SEHK:1332 Stock Report

Market Cap: HK$373.2m

Touyun Biotech Group (1332) Stock Overview

An investment holding company, manufactures and sells packaging products in Hong Kong, the People’s Republic of China, Europe, North and South America, and internationally. More details

1332 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance2/6
Financial Health1/6
Dividends0/6

1332 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW486,488 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
BL
BlackGoat
IN
Investingwilly
RO
RockeTeller
DA
davidlsander
486,488 investors already sharing narratives

Touyun Biotech Group Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Touyun Biotech Group
Historical stock prices
Current Share PriceHK$0.14
52 Week HighHK$0.75
52 Week LowHK$0.067
Beta-0.60
1 Month Change-18.18%
3 Month Change-3.57%
1 Year Change33.66%
3 Year Change-76.72%
5 Year Change-83.13%
Change since IPO-40.58%

Recent News & Updates

Analysis Article Jan 26

Risks Still Elevated At These Prices As Touyun Biotech Group Limited (HKG:1332) Shares Dive 54%

Touyun Biotech Group Limited ( HKG:1332 ) shares have retraced a considerable 54% in the last month, reversing a fair...
Analysis Article Dec 12

Some Confidence Is Lacking In Touyun Biotech Group Limited (HKG:1332) As Shares Slide 40%

The Touyun Biotech Group Limited ( HKG:1332 ) share price has softened a substantial 40% over the previous 30 days...

Recent updates

Analysis Article Jan 26

Risks Still Elevated At These Prices As Touyun Biotech Group Limited (HKG:1332) Shares Dive 54%

Touyun Biotech Group Limited ( HKG:1332 ) shares have retraced a considerable 54% in the last month, reversing a fair...
Analysis Article Dec 12

Some Confidence Is Lacking In Touyun Biotech Group Limited (HKG:1332) As Shares Slide 40%

The Touyun Biotech Group Limited ( HKG:1332 ) share price has softened a substantial 40% over the previous 30 days...
Analysis Article Oct 13

Risks Still Elevated At These Prices As Touyun Biotech Group Limited (HKG:1332) Shares Dive 31%

Touyun Biotech Group Limited ( HKG:1332 ) shareholders won't be pleased to see that the share price has had a very...
Analysis Article Aug 28

Risks Still Elevated At These Prices As Touyun Biotech Group Limited (HKG:1332) Shares Dive 25%

Touyun Biotech Group Limited ( HKG:1332 ) shares have had a horrible month, losing 25% after a relatively good period...
Analysis Article May 30

Risks Still Elevated At These Prices As Touyun Biotech Group Limited (HKG:1332) Shares Dive 49%

Touyun Biotech Group Limited ( HKG:1332 ) shareholders that were waiting for something to happen have been dealt a blow...
Analysis Article Feb 11

Touyun Biotech Group Limited's (HKG:1332) Shares May Have Run Too Fast Too Soon

Touyun Biotech Group Limited's ( HKG:1332 ) price-to-sales (or "P/S") ratio of 2.5x may not look like an appealing...
Analysis Article Sep 15

Revenues Not Telling The Story For Touyun Biotech Group Limited (HKG:1332) After Shares Rise 29%

Touyun Biotech Group Limited ( HKG:1332 ) shareholders are no doubt pleased to see that the share price has bounced 29...
Analysis Article Jul 17

Touyun Biotech Group Limited's (HKG:1332) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Touyun Biotech Group Limited ( HKG:1332 ) shareholders that were waiting for something to happen have been dealt a blow...
Analysis Article Apr 22

Risks Still Elevated At These Prices As Touyun Biotech Group Limited (HKG:1332) Shares Dive 28%

Touyun Biotech Group Limited ( HKG:1332 ) shares have retraced a considerable 28% in the last month, reversing a fair...
Analysis Article Apr 08

Would Touyun Biotech Group (HKG:1332) Be Better Off With Less Debt?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analysis Article Feb 07

What Touyun Biotech Group Limited's (HKG:1332) 46% Share Price Gain Is Not Telling You

Touyun Biotech Group Limited ( HKG:1332 ) shareholders are no doubt pleased to see that the share price has bounced 46...
Analysis Article Dec 18

Some Touyun Biotech Group Limited (HKG:1332) Shareholders Look For Exit As Shares Take 42% Pounding

Touyun Biotech Group Limited ( HKG:1332 ) shareholders that were waiting for something to happen have been dealt a blow...
Analysis Article Sep 19

Touyun Biotech Group (HKG:1332) Is Carrying A Fair Bit Of Debt

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analysis Article Jul 28

Risks To Shareholder Returns Are Elevated At These Prices For Touyun Biotech Group Limited (HKG:1332)

When you see that almost half of the companies in the Packaging industry in Hong Kong have price-to-sales ratios (or...
Analysis Article Sep 13

Here's Why Touyun Biotech Group (HKG:1332) Can Afford Some Debt

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article May 18

Touyun Biotech Group (HKG:1332) Is Making Moderate Use Of Debt

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article Dec 24

Here's Why Touyun Biotech Group (HKG:1332) Can Afford Some Debt

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analysis Article Mar 12

Could The China Touyun Tech Group Limited (HKG:1332) Ownership Structure Tell Us Something Useful?

The big shareholder groups in China Touyun Tech Group Limited ( HKG:1332 ) have power over the company. Large companies...
Analysis Article Jan 15

If You Had Bought China Touyun Tech Group (HKG:1332) Shares A Year Ago You'd Have Earned 380% Returns

While some are satisfied with an index fund, active investors aim to find truly magnificent investments on the stock...
Analysis Article Jan 15

The Executive Chairman of China Touyun Tech Group Limited (HKG:1332), Liang Wang, Just Bought 8.8% More Shares

Those following along with China Touyun Tech Group Limited ( HKG:1332 ) will no doubt be intrigued by the recent...
Analysis Article Dec 11

How Much Of China Touyun Tech Group Limited (HKG:1332) Do Insiders Own?

If you want to know who really controls China Touyun Tech Group Limited ( HKG:1332 ), then you'll have to look at the...

Shareholder Returns

1332HK PackagingHK Market
7D-2.9%3.7%0.8%
1Y33.7%114.0%-1.6%

Return vs Industry: 1332 underperformed the Hong Kong Packaging industry which returned 114% over the past year.

Return vs Market: 1332 exceeded the Hong Kong Market which returned -1.6% over the past year.

Price Volatility

Is 1332's price volatile compared to industry and market?
1332 volatility
1332 Average Weekly Movement11.7%
Packaging Industry Average Movement9.3%
Market Average Movement7.8%
10% most volatile stocks in HK Market16.2%
10% least volatile stocks in HK Market3.7%

Stable Share Price: 1332's share price has been volatile over the past 3 months compared to the Hong Kong market.

Volatility Over Time: 1332's weekly volatility has decreased from 38% to 12% over the past year, but is still higher than 75% of Hong Kong stocks.

About the Company

FoundedEmployeesCEOWebsite
1989296n/atouyunbiotech.com.hk

Touyun Biotech Group Limited, an investment holding company, manufactures and sells packaging products in Hong Kong, the People’s Republic of China, Europe, North and South America, and internationally. The company operates through three segments: Packaging Products Business, Treasury Investment Business, and Chlamydomonas Reinhardtii Products Business. The Packaging Products Business segment manufactures and sells watch and jewelry boxes, eyewear cases, bags and pouches, and display units.

Touyun Biotech Group Limited Fundamentals Summary

How do Touyun Biotech Group's earnings and revenue compare to its market cap?
1332 fundamental statistics
Market capHK$373.19m
Earnings (TTM)HK$13.06m
Revenue (TTM)HK$66.97m
29.0x
P/E Ratio
5.7x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1332 income statement (TTM)
RevenueHK$66.97m
Cost of RevenueHK$50.75m
Gross ProfitHK$16.22m
Other ExpensesHK$3.16m
EarningsHK$13.06m

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)0.0047
Gross Margin24.22%
Net Profit Margin19.51%
Debt/Equity Ratio1,857.5%

How did 1332 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/05 11:37
End of Day Share Price 2026/08/05 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Touyun Biotech Group Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.